In 1997, Levaquin, manufactured by Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc., was approved by the FDA. In 2006, Public Citizen, a citizen advocacy organization, delivered the message to the FDA that a black box warning was needed for Levaquin due … Continue reading →